- Home
- OSUR vs CMPS Comparison
OSUR vs CMPS Comparison
Compare OSUR & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- CMPS
- Stock Information
- Founded
- OSUR 2000
- CMPS 2020
- Country
- OSUR United States
- CMPS United Kingdom
- Employees
- OSUR N/A
- CMPS N/A
- Industry
- OSUR Medical/Dental Instruments
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- OSUR Health Care
- CMPS Health Care
- Exchange
- OSUR Nasdaq
- CMPS Nasdaq
- Market Cap
- OSUR 289.4M
- CMPS 280.2M
- IPO Year
- OSUR 1986
- CMPS 2020
- Fundamental
- Price
- OSUR $4.11
- CMPS $4.39
- Analyst Decision
- OSUR Buy
- CMPS Strong Buy
- Analyst Count
- OSUR 3
- CMPS 7
- Target Price
- OSUR $6.67
- CMPS $30.67
- AVG Volume (30 Days)
- OSUR 883.9K
- CMPS 835.3K
- Earning Date
- OSUR 11-06-2024
- CMPS 10-31-2024
- Dividend Yield
- OSUR N/A
- CMPS N/A
- EPS Growth
- OSUR N/A
- CMPS N/A
- EPS
- OSUR 0.15
- CMPS N/A
- Revenue
- OSUR $224,263,000.00
- CMPS N/A
- Revenue This Year
- OSUR N/A
- CMPS N/A
- Revenue Next Year
- OSUR N/A
- CMPS N/A
- P/E Ratio
- OSUR $27.24
- CMPS N/A
- Revenue Growth
- OSUR N/A
- CMPS N/A
- 52 Week Low
- OSUR $3.72
- CMPS $4.00
- 52 Week High
- OSUR $8.45
- CMPS $12.75
- Technical
- Relative Strength Index (RSI)
- OSUR 56.76
- CMPS 43.66
- Support Level
- OSUR $3.78
- CMPS $4.00
- Resistance Level
- OSUR $4.09
- CMPS $4.91
- Average True Range (ATR)
- OSUR 0.15
- CMPS 0.26
- MACD
- OSUR 0.03
- CMPS 0.07
- Stochastic Oscillator
- OSUR 84.71
- CMPS 58.24
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.